Blank

Pegintron label

Common Questions and Answers about Pegintron label

peg-intron

Avatar m tn The Italian study compared Pegasys with PegIntron in a prospective, randomized, open-label, single-center trial in 320 treatment-naives. Ribavirin was dosed the same for both arms: 1000 mg/day for patients 75 kg. Median HCV RNA was about 600,000 IU/ml. 66% were genotype 1 and 33-41% were genotype 2-3. Overall SVR rate was 68% for Pegasys and 54%. For genotype 1-4, SVR was 55% for Pegasys and 40% for PegIntron.
1579934 tn?1431268911 Without delving in to the mechanics of the meds, he suggested I try switching to Pegintron. I also used off label dose and duration, but the difference in response was remarkable. I had a much improved initial response, clearing the second time between weeks 4 and 8. I’m not sure how much this info is worth, given the likelihood of upcoming changes in treatment protocol; that was my experience though.
1084115 tn?1385228589 3 Pharmacokinetics Methadone The pharmacokinetics of concomitant administration of methadone and PegIntron were evaluated in 18 PegIntron-naïve chronic hepatitis C subjects receiving 1.5 mcg/kg PegIntron subcutaneously weekly. All subjects were on stable methadone maintenance therapy receiving ≥40 mg/day prior to initiating PegIntron. Mean methadone AUC was approximately 16% higher after 4 weeks of PegIntron treatment as compared to baseline.
408795 tn?1324935675 FDA Hepatitis Update - Important updates to PegIntron labeling On December 22, 2011, the Food and Drug Administration approved revisions to the product labeling for PegIntron to include the use of PegIntron with hepatitis C virus (HCV) NS3/4A protease inhibitors for the treatment of genotype 1, chronic hepatitis C (CHC) infection. Additionally, the product labeling was update to include revisions to the text regarding the use of PegIntron in patients with neuropsychiatric disorders.
Avatar m tn 1st dose reduction of PegIntron is to 1 mcg/kg/week, 2nd dose reduction (if needed) of PegIntron is to 0.5 mcg/kg/week. If platelets go down below 25,000 the standard protocol says to stop all treatment. There is a way around the platelet issue if the center will do it. That is platelet transfusions and/or Promacta/Eltrombopag a drug that can raise platelets. But these are temporary fixes so they would be need to be done (transfusions) and taken (Promacta) over length of treatment.
Avatar f tn Hi: Started 5th week (PegIntron, Incivek(telaprevir) and Ribavirin. Want to share some things I've learned. Got "Sea Bands"- to help make nausea go away(just put them on, see how they do).They're simple, just accupressure, no chemicals. By now you know you must eat w/ the Incivek; and UGH- supposed to get 20 Grams of fat at that time.. This is challenging for me, got ginger snaps & cream cheese- Also noticing that pot pies(chicken pot pie by Banquet or Marie Callender.
Avatar n tn An interferon without all the side effects of Pegusus or Pegintron. Looks very interesting. I am thinking about participating. http://clinicaltrials.gov/ct2/show/NCT00565539?
Avatar m tn You had a low starting VL and I'm not surprised that your doctor was so enthusiastic at your rapid response. He won't have to watch you suffer for so long. I also recently read the Rebetol label Bill is referring to and if it's on the label, it must be a good recommendation. Drug companies have to prove everything to get the FDA label language changed. Your doctor's opinion at 24 weeks is more important than any other opinion.
Avatar f tn s how most of us see it), Pegasys is not weight based, whereas Pegintron is. If one is overweight, Pegintron seems to be the way to go. Talk to your Dr. I switched from a gastro to a hepatologist in my 6th week of tx. My hep dr. told me (a little late) that he would have started me on Pegintron due to my weight. Something to consider and hopefully others will back this up with data. All the best!
Avatar m tn In a 28-week treatment regimen in which patients received 4 weeks of PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) prior to the addition of boceprevir (800 mg TID), the rate of sustained virological response at 12 weeks after the end of treatment (SVR 12) was 57 percent (ITT).
4384361 tn?1399998230 But, the fact was that I relapsed with Pegasys and the doctor wanted me to do PegIntron. So far, it looks like PegIntron has been successful. (I am currently waiting for the results from my 6-month post VL test, but previous tests have been undetectable). I would not worry if the doctor cannot get the rx changed.
442340 tn?1326817417 Having done both Pegintron and Pegasys I had a much harder time with Pegintron. I had a fever 40 out of 48 weeks the day after my shot nite with the Pegintron and maybe only once or twice with Pegasys. all people handle tx differently so only time will tell how you react. On both tx's the red and white blood counts had issues that are easy to controled by rescue drugs.
6048407 tn?1378670104 Did your doctor say why he wanted you to use Pegintron? Is it due to the dual infection? Is the Pegintron stronger? Just curious.
479244 tn?1271563659 This is where I think the info came from regarding my original decision to go with the pegintron.... less relapse rate, less sides, stays in system shorter amt. of time when you come off , etc. My new nurse, said that study had a lot of flaws and she did not put a lot of faith in it and talked me into pegysus... any comments would be appreciated.
Avatar m tn My doctor switched me to 80 mcg Pegintron wirh same dose of Riba. Can someone please tell me if its OK for me (in terms of chances of achieving SVR) or advise something better?Thanks.
Avatar f tn Is Pegasys just as good as Pegintron? My insurance refused Pegintron. Any information will be most welcome. New to the group.
Avatar f tn thanks all... viraferonpeg is like a big pen sort of.. its got powder and solution in it..
996769 tn?1249681013 here's an example of a label that says do not use if you have --- thyroid disease Caution: Do not use BreastSuccess if you are pregnant, nursing, or have any of the following conditions: high blood pressure, heart disease, thyroid disease, glaucoma, diabetes, difficulty urinating due to prostate enlargement, or if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for two (2
Avatar m tn Among subjects with detectable HCV-RNA at TW8 who had attained undetectable HCV-RNA at TW24 and completed at least 28 weeks of treatment, the SVR rates were 66% (45/68) in VICTRELIS-RGT arm (4 weeks of PegIntron and REBETOL then 24 weeks of VICTRELIS with PegIntron and REBETOL followed by 20 weeks of PegIntron and REBETOL alone) and 75% (55/73) in VICTRELIS-PR48 arms (4 weeks of PegIntron and REBETOL then 44 weeks of VICTRELIS with PegIntron and REBETOL).